HeartPoint Global is rolling out an array of innovative new technologies that are garnering mindshare and saving lives.

“What we do, really, is social capital, but it’s also serious business,” says Seth Bogner, chairman and CEO of Heartpoint Global.

HeartPoint Global is the embodiment of putting people first — the quality that defines every Social Capital company — in that it makes groundbreaking medical devices to treat life-threatening cardiovascular diseases that affect millions of people worldwide every year.

The company focuses on children in the U.S. with congenital heart disease and is determined to bring cardiac care to the 90% of children in the world who are underserved. “It’s not just about poor kids, it’s not just about underprivileged kids. It’s about the 90% of the kids or people in the world that don’t have access to cardiac care, which is a ridiculous number if you think about the technology we have available to us,” Seth says.

Seth, a former Wall Street executive who became leader of the company in 2016, has found that his work as a leader aligns with his spiritual purpose. “I would consider myself a spiritual person, and I believe that the highest form of service that you could do is receive something and then give it back out,” he says. “And that type of service is something that I was asking for a long time in my personal practice … and then this business showed up and I got deeper and deeper into it, and I got more and more excited about what we were doing.”

One key advance that HeartPoint Global has pioneered is an improvement on a 70-year-old surgical procedure called pulmonary artery banding that had a very high mortality rate. HeartPoint Global came up with a minimally-invasive alternative that reduces the surgical time from six hours to 20 minutes and is now seeking FDA approval.

“We’ve taken old science and put new technology around it and have a solution for thousands, if not millions,” Seth says.

HeartPoint Global developed it in collaboration with partners in Switzerland who called Seth’s attention to the opportunity to improve on pulmonary artery banding. “Were able to, with the help of our money and their ingenuity, put together something that replaced that surgery in a minimally invasive way, taking away a lot of the risk, doing it without the heavy full anesthesia, and very, very quickly be able to do a procedure in 20 minutes versus six hours,” Seth says.

It is just one of the solutions HeartPoint Global offers — innovations that are garnering more and more awards. The company is now the recipient of the Cardiovascular Research Foundation’s TCT Shark Tank Award, the Horizon EIC Accelerator Seal of Excellence and the UCSF Stanford Pediatric device consortium Accelerator Pitch Competition. In raising the company’s profile, Seth is attracting the attention of many other thought leaders in its industry and taking an active role in defining what it means to be a Social Capital company.

Seth recently spoke with Chris Benguhe, founder and president of the Dave Alexander Center for Social Capital and publisher of the Social Capital Insider, about his work. Click on the link here to watch our video interview.